Legal & General Group
ALXO icon

Legal & General Group’s ALX Oncology ALXO Stock Holding History

Legal & General Group’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,860
Closed -$2.4K – 3423
2025
Q1 		$2.4K Hold
3,860
– – ﹤0.01% 3344
2024
Q4 		$6.45K Hold
3,860
– – ﹤0.01% 3315
2024
Q3 		$7.04K Sell
3,860
-22,027
-85% -$81.9K ﹤0.01% 3330
2024
Q2 		$156K Buy
25,887
+8,701
+51% +$107K ﹤0.01% 2697
2024
Q1 		$192K Buy
17,186
+14,897
+651% +$209K ﹤0.01% 2686
2023
Q4 		$34.1K Buy
2,289
+684
+43% +$6.49K ﹤0.01% 2869
2023
Q3 		$7.7K Sell
1,605
-576
-26% -$3.13K ﹤0.01% 3314
2023
Q2 		$16.4K Sell
2,181
-1,083
-33% -$7.09K ﹤0.01% 3195
2023
Q1 		$14.8K Sell
3,264
-3,592
-52% -$27.2K ﹤0.01% 3143
2022
Q4 		$77.3K Hold
6,856
– – ﹤0.01% 2872
2022
Q3 		$65K Buy
6,856
+1,547
+29% +$18K ﹤0.01% 2921
2022
Q2 		$43K Buy
5,309
+1,534
+41% +$16.7K ﹤0.01% 3023
2022
Q1 		$64K Hold
3,775
– – ﹤0.01% 2954
2021
Q4 		$81K Buy
3,775
+33
+0.9% +$1.42K ﹤0.01% 2951
2021
Q3 		$276K Buy
3,742
+1,598
+75% +$107K ﹤0.01% 2583
2021
Q2 		$117K Buy
2,144
+39
+2% +$2.33K ﹤0.01% 2682
2021
Q1 		$155K Buy
2,105
+746
+55% +$58.7K ﹤0.01% 2500
2020
Q4 		$117K Buy
1,359
+289
+27% +$17.4K ﹤0.01% 2541
2020
Q3 		$40K Buy
+1,070
New +$42.1K ﹤0.01% 2763

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Legal & General Group's ALXO Position: Q2 2025 in Review

Legal & General Group sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 3,860 shares — an estimated $2.4K sold.

Legal & General Group first reported a position in ALXO in Q3 2020 and held it in 19 quarters. The position peaked at $276K in Q3 2021. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.

  • Legal & General Group reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 3,860 ALX Oncology shares in Q2 2025, an estimated $2.4K.
  • Legal & General Group first reported a position in ALX Oncology in Q3 2020 and held it in 19 quarters.
  • Legal & General Group's ALX Oncology position peaked at $276K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.